Metabolix, Inc. Announces $15 Million Equity Private Placement

Metabolix, Inc. MBLX, an advanced biomaterials company focused on sustainable solutions for the plastics industry, announced today that it has entered into a definitive agreement with Jack W. Schuler, Birchview Capital, Hong Kong Sino-Science Oil & Gas Co., Ltd., certain members of the Company's board of directors and executive management team and certain other investors, for the sale of an aggregate of approximately $15 million of the Company's equity securities in a private placement. The closing of the private placement is subject to customary conditions. Under the terms of the agreement, Metabolix has agreed to sell an aggregate of 4,370,000 shares of its common stock at a price of $3.32 per share, the closing price of the Company's common stock on NASDAQ on June 11, 2015. In addition, the investors will purchase warrants covering up to an aggregate of 3,933,000 additional shares of Metabolix common stock.  The warrants have a purchase price of $0.125 per warrant, a four-year term and are immediately exercisable at an exercise price of $3.98 per share, representing a 20% premium to the purchase price of the common stock. The Company could realize approximately $15.6 million in additional proceeds See full press release